Qihan's QT-019B program is supported by IND clearance for rSLE from both the US FDA and the China NMPA. The FDA has also granted Fast Track Designation for the SLE-ITP indication. Phase 1 enrollment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback